Neon Therapeutics, Inc.
SEC CIK 1694187 · NTGN · last insider filing 2020-05-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sherwin Stephen A | Director | filed 2018 - 2020 |
| Tepper Robert I | Director | filed 2018 - 2020 |
| Lander Eric S | Director | filed 2018 - 2020 |
| Pfeffer Cary | Director | filed 2018 - 2020 |
| Bazemore Robert B | Director | filed 2018 - 2020 |
| Kamen Robert | Director | filed 2018 - 2020 |
| O'Dowd Hugh | Director · President & CEO | filed 2018 - 2020 |
| Zausner Meryl | Director | filed 2018 - 2020 |
| Adams Julian | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Al-Wakeel Yasir B. | Chief Financial Officer | filed 2018 - 2020 |
| Gaynor Richard | President of R&D | filed 2018 - 2020 |
| Siegel Jolie | VP, General Counsel | filed 2019 - 2020 |
| ANG Robert | Chief Business Officer | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.